# Nuvation Bio (NUVB, NUVB.WS): value investors who own it

2 value investors held Nuvation Bio in their Q3 2026 13F, led by Abrams Capital Management, Greenlight Capital.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Abrams Capital Management | 0.1% | $7.2m | Unchanged | 22 |
| Greenlight Capital | 0.0% | $199k | Unchanged | 22 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-08-19 | Hattersley Gary | CHIEF SCIENTIFIC OFFICER | Sold | 100000 | $709k |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/nuvb). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.